Increased ECM expression is well-documented in IBD, where remodeling is a consistent feature implicated in disease pathogenesis [13], and elevated serum levels of ECM proteins such as tenascin C are observed in IBD patients [14]. This evidence concerns the gene TNC and inflammatory bowel disease.